Next-generation Sequencing Services Market Size, Share & Trends Analysis Report By Service Type (Human Genome Sequencing, Gene Regulation Services), By Workflow, By End-use, And Segment Forecasts, 2023 - 2030
This report can be delivered to the clients within 2 Business Days
Next-generation Sequencing Services Market Growth & Trends
The global next-generation sequencing services market size is expected to reach USD 24.5 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 22.56% from 2023 to 2030. The development of next-generation sequencing (NGS) technologies has revolutionized gene sequencing in terms of reproducibility and cost savings. This has resulted in the introduction of several advancements in NGS technology to promote its usage in clinical labs and hospitals. Most current innovations in this field revolve around simplifying the usage of seq-technology and making it more sophisticated. These factors have driven the uptake of NGS services across various end-users.
Next-generation sequencing has progressed from research to clinical use in the last five years. Around 14 nations have launched large-scale genome sequencing programs, with nearly 60 million people expected to have their genome analyzed by 2025. Conventional disease testing service providers have broadened their portfolio with a rising trend of seq-based genetic tests. For instance, ARUP Laboratories announced the release of new coronavirus tests in March 2022, and IDbyDNA, Inc. partnered with another firm to introduce new coronavirus tests, an NGS test for respiratory illnesses, to aid physicians in evaluating patients with pneumonia and some other respiratory problems.
With the rising trend of high throughput sequencing within the pharma and biotech industry, there is a need for more developments to improve the speed and convenience of high throughput seq-platforms and simplify workflows. As a result, companies are focusing on the development of solutions to simplify the amplification and purification of samples and starting input. In March 2022, Illumina, Inc. announced the release of TruSigh Oncology (TSO) Comprehensive (EU), a comprehensive diagnostic that evaluates several tumor genes and indicators to identify a patient's cancer's individual molecular profile. The in vitro diagnostic (IVD) kit would assist in influencing genomic decisions for patients with cancer across Europe, with its global debut taking place first in Europe.
Next-generation Sequencing Services Market Report Highlights
Next-generation Sequencing Services Market Growth & Trends
The global next-generation sequencing services market size is expected to reach USD 24.5 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 22.56% from 2023 to 2030. The development of next-generation sequencing (NGS) technologies has revolutionized gene sequencing in terms of reproducibility and cost savings. This has resulted in the introduction of several advancements in NGS technology to promote its usage in clinical labs and hospitals. Most current innovations in this field revolve around simplifying the usage of seq-technology and making it more sophisticated. These factors have driven the uptake of NGS services across various end-users.
Next-generation sequencing has progressed from research to clinical use in the last five years. Around 14 nations have launched large-scale genome sequencing programs, with nearly 60 million people expected to have their genome analyzed by 2025. Conventional disease testing service providers have broadened their portfolio with a rising trend of seq-based genetic tests. For instance, ARUP Laboratories announced the release of new coronavirus tests in March 2022, and IDbyDNA, Inc. partnered with another firm to introduce new coronavirus tests, an NGS test for respiratory illnesses, to aid physicians in evaluating patients with pneumonia and some other respiratory problems.
With the rising trend of high throughput sequencing within the pharma and biotech industry, there is a need for more developments to improve the speed and convenience of high throughput seq-platforms and simplify workflows. As a result, companies are focusing on the development of solutions to simplify the amplification and purification of samples and starting input. In March 2022, Illumina, Inc. announced the release of TruSigh Oncology (TSO) Comprehensive (EU), a comprehensive diagnostic that evaluates several tumor genes and indicators to identify a patient's cancer's individual molecular profile. The in vitro diagnostic (IVD) kit would assist in influencing genomic decisions for patients with cancer across Europe, with its global debut taking place first in Europe.
Next-generation Sequencing Services Market Report Highlights
- By service type, human genome sequencing held the largest revenue share in 2022 owing to greater penetration of whole genome and whole exome sequencing
- Gene regulation services, particularly small RNA sequencing and ChIP-seq, are anticipated to grow at a lucrative pace during the forecast period. Rising investment in RNA sequencing is fueling the growth of gene regulation services
- The larger revenue share of sequencing services as compared to other workflow steps can be attributed to an increase in the installation of sequencing platforms. High maintenance and recovery costs of this step have also resulted in greater revenue generation
- By end-use, the universities and other research entities segment held the largest revenue share in 2022 owing to the growing application of NGS technology for cancer prognosis as well as diagnosis and major projects taken up by academicians and universities
- North America dominated the market in 2022 owing to higher penetration of the technology in this region and the availability of funds to employ the technique and derive research findings for disease targeting
- Companies such as GENEWIZ and Novogene Corporation are engaged in offering NGS services based on platforms from major NGS developers. Companies such as Illumina and BGI, on the other hand, are involved in developing sequencing instruments and offering services to research entities
- In November 2021, Novogene stated during the 44th Annual Gathering of Molecular Biological Society of Japan (MSBJ) in Japan that they will be launching single-cell sequencing services specifically for their Japanese customers
- GENEWIZ scientists are assisting in identifying the NGS solution for the projects. The NeXT Dx Test was launched by Personalis, Inc. to assist oncologists in identifying new therapy and clinical trial choices for cancer patients
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Research Methodology
1.2 Information Procurement
1.2.1 Sample Size For The Study On Next Generation Sequencing Services Market:
1.2.1.1 Service Providers:
1.2.1.2 Secondary Data Sources:
1.3 Information Or Data Analysis
1.4 Market Formulation & Validation
1.5 Global Market: Cagr Calculation
1.6 Research Assumptions
1.7 Objectives
1.7.1 Objective 1:
1.7.2 Objective 2:
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Segment Snapshot
2.4 Competitive Landscape Snapshot
CHAPTER 3 MARKET VARIABLES, TRENDS, & SCOPE
3.1 Market Trends & Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Decline In Sequencing Prices
3.2.1.2 Growing Awareness Pertaining To Women & Reproductive Health
3.2.1.3 Strategies Undertaken For Implementation Of Clinical Ngs
3.2.2 Market Restraint Analysis
3.2.2.1 Challenges Pertaining To Implementation Of Large-Scale Ngs Analysis Workflows
3.2.2.2 Analytical Challenges In Single Cell Sequencing
3.3 Penetration And Growth Prospect Mapping For Service Type, 2022 (Usd Million)
3.4 Impact Of Covid-19 Pandemic On Ngs Services Market
3.4.1 Impact On The Supply Chain
3.4.2 Association Of Covid-19 With Next-Generation Sequencing
3.5 Business Environment Analysis
3.5.1 Swot Analysis; By Factor (Political & Legal, Economic, And Technological)
3.5.2 Porter’s Five Forces Analysis
CHAPTER 4 SERVICE TYPE BUSINESS ANALYSIS
4.1 Next-Generation Sequencing Services Market: Service Type Movement Analysis
4.2 Human Genome Sequencing Services
4.2.1 Human Genome Sequencing Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3 Single-Cell Sequencing Services
4.3.1 Single-Cell Sequencing Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4 Microbial Genome-Based Sequencing Services
4.4.1 Microbial Genome-Based Sequencing Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.5 Gene Regulation Services
4.5.1 Gene Regulation Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.5.2 Small Rna Sequencing Service
4.5.2.1 Small Rna Sequencing Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.5.3 Chip Sequencing Service
4.5.3.1 Chip Sequencing Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.5.4 Other Gene Regulation-Based Service
4.5.4.1 Other Gene Regulation-Based Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.6 Animal & Plant Sequencing Services
4.6.1 Animal & Plant Sequencing Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.7 Other Sequencing Services
4.7.1 Other Sequencing Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 5 WORKFLOW BUSINESS ANALYSIS
5.1 Next Generation Sequencing Services Market: Workflow Movement Analysis
5.2 Pre Sequencing Services
5.2.1 Pre Sequencing Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 Sequencing Services
5.3.1 Sequencing Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Data Analysis Service
5.4.1 Data Analysis Service Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 6 END-USE BUSINESS ANALYSIS
6.1 Next Generation Sequencing Services Market: End-Use Movement Analysis
6.2 Universities & Other Research Entities
6.2.1 Next-Generation Sequencing Services Market For Universities & Other Research Entities, 2018 - 2030 (USD Million)
6.3 Hospitals & Clinics
6.3.1 Next-Generation Sequencing Services Market For Hospitals & Clinics, 2018 - 2030 (USD Million)
6.4 Pharma & Biotech Entities
6.4.1 Next-Generation Sequencing Services Market For Pharma & Biotech Entities, 2018 - 2030 (USD Million)
6.5 Others
6.5.1 Next-Generation Sequencing Services Market For Other End Use, 2018 - 2030 (USD Million)
CHAPTER 7 NEXT-GENERATION SEQUENCING SERVICES MARKET: REGIONAL ESTIMATES AND TREND ANALYSIS, BY SERVICE TYPE, WORKFLOW, & END-USE
7.1 North America
7.1.1 Swot Analysis:
7.1.1.1 North America Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.1.2 U.S.
7.1.2.1 Key Country Dynamics
7.1.2.2 Target Disease Prevalence
7.1.2.3 Competitive Scenario
7.1.2.4 Regulatory Framework
7.1.2.5 Reimbursement Scenario
7.1.2.6 U.S. Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.1.3 Canada
7.1.3.1 Key Country Dynamics
7.1.3.2 Target Disease Prevalence
7.1.3.3 Competitive Scenario
7.1.3.4 Regulatory Framework
7.1.3.5 Reimbursement Scenario
7.1.3.6 Canada Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.2 Europe
7.2.1 Swot Analysis:
7.2.1.1 Europe Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.2.2 Uk
7.2.2.1 Key Country Dynamics
7.2.2.2 Target Disease Prevalence
7.2.2.3 Competitive Scenario
7.2.2.4 Regulatory Framework
7.2.2.5 Reimbursement Scenario
7.2.2.6 Uk Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.2.3 Germany
7.2.3.1 Key Country Dynamics
7.2.3.2 Target Disease Prevalence
7.2.3.3 Competitive Scenario
7.2.3.4 Regulatory Framework
7.2.3.5 Reimbursement Scenario
7.2.3.6 Germany Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.2.4 France
7.2.4.1 Key Country Dynamics
7.2.4.2 Target Disease Prevalence
7.2.4.3 Competitive Scenario
7.2.4.4 Regulatory Framework
7.2.4.1 Reimbursement Scenario
7.2.4.2 France Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.2.5 Spain
7.2.5.1 Key Country Dynamics
7.2.5.2 Target Disease Prevalence
7.2.5.3 Competitive Scenario
7.2.5.4 Regulatory Framework
7.2.5.5 Reimbursement Scenario
7.2.5.6 Spain Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.2.6 Italy
7.2.6.1 Key Country Dynamics
7.2.6.2 Target Disease Prevalence
7.2.6.3 Competitive Scenario
7.2.6.4 Regulatory Framework
7.2.6.1 Reimbursement Scenario
7.2.6.2 Italy Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.2.7 Denmark
7.2.7.1 Key Country Dynamics
7.2.7.2 Target Disease Prevalence
7.2.7.3 Competitive Scenario
7.2.7.4 Regulatory Framework
7.2.7.5 Reimbursement Scenario
7.2.7.6 Denmark Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.2.8 Sweden
7.2.8.1 Key Country Dynamics
7.2.8.2 Target Disease Prevalence
7.2.8.3 Competitive Scenario
7.2.8.4 Regulatory Framework
7.2.8.1 Reimbursement Scenario
7.2.8.2 Sweden Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.2.9 Norway
7.2.9.1 Key Country Dynamics
7.2.9.2 Target Disease Prevalence
7.2.9.3 Competitive Scenario
7.2.9.4 Regulatory Framework
7.2.9.5 Reimbursement Scenario
7.2.9.6 Norway Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.2.10 Switzerland
7.2.10.1 Key Country Dynamics
7.2.10.2 Target Disease Prevalence
7.2.10.3 Competitive Scenario
7.2.10.4 Regulatory Framework
7.2.10.5 Reimbursement Scenario
7.2.10.6 Switzerland Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.3 Asia Pacific
7.3.1 Swot Analysis:
7.3.1.1 Asia Pacific Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.3.2 Japan
7.3.2.1 Key Country Dynamics
7.3.2.2 Target Disease Prevalence
7.3.2.3 Competitive Scenario
7.3.2.4 Regulatory Framework
7.3.2.5 Reimbursement Scenario
7.3.2.6 Japan Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.3.3 China
7.3.3.1 Key Country Dynamics
7.3.3.2 Target Disease Prevalence
7.3.3.3 Competitive Scenario
7.3.3.4 Regulatory Framework
7.3.3.5 Reimbursement Scenario
7.3.3.6 China Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.3.4 India
7.3.4.1 Key Country Dynamics
7.3.4.2 Target Disease Prevalence
7.3.4.3 Competitive Scenario
7.3.4.4 Regulatory Framework
7.3.4.5 Reimbursement Scenario
7.3.4.6 India Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.3.5 Australia
7.3.5.1 Key Country Dynamics
7.3.5.2 Target Disease Prevalence
7.3.5.3 Competitive Scenario
7.3.5.4 Regulatory Framework
7.3.5.5 Reimbursement Scenario
7.3.5.6 Australia Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.3.6 Thailand
7.3.6.1 Key Country Dynamics
7.3.6.2 Target Disease Prevalence
7.3.6.3 Competitive Scenario
7.3.6.4 Regulatory Framework
7.3.6.5 Reimbursement Scenario
7.3.6.6 Thailand Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.3.7 South Korea
7.3.7.1 Key Country Dynamics
7.3.7.2 Target Disease Prevalence
7.3.7.3 Competitive Scenario
7.3.7.4 Regulatory Framework
7.3.7.5 Reimbursement Scenario
7.3.7.6 South Korea Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.3.8 Singapore
7.3.8.1 Key Country Dynamics
7.3.8.2 Target Disease Prevalence
7.3.8.3 Competitive Scenario
7.3.8.4 Regulatory Framework
7.3.8.5 Reimbursement Scenario
7.3.8.6 Singapore Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.4 Latin America
7.4.1 Swot Analysis:
7.4.1.1 Latin America Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.4.2 Brazil
7.4.2.1 Key Country Dynamics
7.4.2.2 Target Disease Prevalence
7.4.2.3 Competitive Scenario
7.4.2.4 Regulatory Framework
7.4.2.5 Reimbursement Scenario
7.4.2.6 Brazil Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.4.3 Mexico
7.4.3.1 Key Country Dynamics
7.4.3.2 Target Disease Prevalence
7.4.3.3 Competitive Scenario
7.4.3.4 Regulatory Framework
7.4.3.5 Reimbursement Scenario
7.4.3.6 Mexico Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.4.4 Argentina
7.4.4.1 Key Country Dynamics
7.4.4.2 Target Disease Prevalence
7.4.4.3 Competitive Scenario
7.4.4.4 Regulatory Framework
7.4.4.5 Reimbursement Scenario
7.4.4.6 Argentina Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.5 Mea
7.5.1 Swot Analysis:
7.5.1.1 Mea Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.5.2 South Africa
7.5.2.1 Key Country Dynamics
7.5.2.2 Target Disease Prevalence
7.5.2.3 Competitive Scenario
7.5.2.4 Regulatory Framework
7.5.2.5 Reimbursement Scenario
7.5.2.6 South Africa Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.5.3 Saudi Arabia
7.5.3.1 Key Country Dynamics
7.5.3.2 Target Disease Prevalence
7.5.3.3 Competitive Scenario
7.5.3.4 Regulatory Framework
7.5.3.5 Reimbursement Scenario
7.5.3.6 Saudi Arabia Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.5.4 Uae
7.5.4.1 Key Country Dynamics
7.5.4.2 Target Disease Prevalence
7.5.4.3 Competitive Scenario
7.5.4.4 Regulatory Framework
7.5.4.5 Reimbursement Scenario
7.5.4.6 Uae Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.5.5 Kuwait
7.5.5.1 Key Country Dynamics
7.5.5.2 Target Disease Prevalence
7.5.5.3 Competitive Scenario
7.5.5.4 Regulatory Framework
7.5.5.5 Reimbursement Scenario
7.5.5.6 Kuwait Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
CHAPTER 8 COMPETITIVE LANDSCAPE
8.1 Company Categorization
8.2 Company Market Share Analysis, 2022
8.3 Strategy Mapping
8.4 Company Profiles/Listing
8.4.1 QUEST DIAGNOSTICS INCORPORATED
8.4.1.1 Overview
8.4.1.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3 Product Benchmarking
8.4.1.4 Strategic Initiatives
8.4.2 ARUP LABORATORIES
8.4.2.1 Overview
8.4.2.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3 Product Benchmarking
8.4.2.4 Strategic Initiatives
8.4.3 APPLIED BIOLOGICAL MATERIALS, INC. (ABM)
8.4.3.1 Overview
8.4.3.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3 Product Benchmarking
8.4.3.4 Strategic Initiatives
8.4.4 NOVOGENE CO, LTD.
8.4.4.1 Overview
8.4.4.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3 Product Benchmarking
8.4.4.4 Strategic Initiatives
8.4.5 AZENTA LIFE SCIENCES (GENEWIZ)
8.4.5.1 Overview
8.4.5.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3 Product Benchmarking
8.4.5.4 Strategic Initiatives
8.4.6 NANOSTRING
8.4.6.1 Overview
8.4.6.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3 Product Benchmarking
8.4.6.4 Strategic Initiatives
8.4.7 ILLUMINA, INC.
8.4.7.1 Overview
8.4.7.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3 Product Benchmarking
8.4.7.4 Strategic Initiatives
8.4.8 PACBIO
8.4.8.1 Overview
8.4.8.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3 Product Benchmarking
8.4.8.4 Strategic Initiatives
8.4.9 VERITAS
8.4.9.1 Overview
8.4.9.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3 Product Benchmarking
8.4.9.4 Strategic Initiatives
8.4.10 BGI (BEIJING GENOMICS INSTITUTE)
8.4.10.1 Overview
8.4.10.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3 Product Benchmarking
8.4.10.4 Strategic Initiatives
8.4.11 GENE BY GENE LTD.
8.4.11.1 Overview
8.4.11.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.11.3 Product Benchmarking
8.4.11.4 Strategic Initiatives
8.4.12 LUCIGEN CORPORATION
8.4.12.1 Overview
8.4.12.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.12.3 Product Benchmarking
8.4.12.4 Strategic Initiatives
1.1 Research Methodology
1.2 Information Procurement
1.2.1 Sample Size For The Study On Next Generation Sequencing Services Market:
1.2.1.1 Service Providers:
1.2.1.2 Secondary Data Sources:
1.3 Information Or Data Analysis
1.4 Market Formulation & Validation
1.5 Global Market: Cagr Calculation
1.6 Research Assumptions
1.7 Objectives
1.7.1 Objective 1:
1.7.2 Objective 2:
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Segment Snapshot
2.4 Competitive Landscape Snapshot
CHAPTER 3 MARKET VARIABLES, TRENDS, & SCOPE
3.1 Market Trends & Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Decline In Sequencing Prices
3.2.1.2 Growing Awareness Pertaining To Women & Reproductive Health
3.2.1.3 Strategies Undertaken For Implementation Of Clinical Ngs
3.2.2 Market Restraint Analysis
3.2.2.1 Challenges Pertaining To Implementation Of Large-Scale Ngs Analysis Workflows
3.2.2.2 Analytical Challenges In Single Cell Sequencing
3.3 Penetration And Growth Prospect Mapping For Service Type, 2022 (Usd Million)
3.4 Impact Of Covid-19 Pandemic On Ngs Services Market
3.4.1 Impact On The Supply Chain
3.4.2 Association Of Covid-19 With Next-Generation Sequencing
3.5 Business Environment Analysis
3.5.1 Swot Analysis; By Factor (Political & Legal, Economic, And Technological)
3.5.2 Porter’s Five Forces Analysis
CHAPTER 4 SERVICE TYPE BUSINESS ANALYSIS
4.1 Next-Generation Sequencing Services Market: Service Type Movement Analysis
4.2 Human Genome Sequencing Services
4.2.1 Human Genome Sequencing Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3 Single-Cell Sequencing Services
4.3.1 Single-Cell Sequencing Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4 Microbial Genome-Based Sequencing Services
4.4.1 Microbial Genome-Based Sequencing Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.5 Gene Regulation Services
4.5.1 Gene Regulation Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.5.2 Small Rna Sequencing Service
4.5.2.1 Small Rna Sequencing Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.5.3 Chip Sequencing Service
4.5.3.1 Chip Sequencing Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.5.4 Other Gene Regulation-Based Service
4.5.4.1 Other Gene Regulation-Based Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.6 Animal & Plant Sequencing Services
4.6.1 Animal & Plant Sequencing Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.7 Other Sequencing Services
4.7.1 Other Sequencing Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 5 WORKFLOW BUSINESS ANALYSIS
5.1 Next Generation Sequencing Services Market: Workflow Movement Analysis
5.2 Pre Sequencing Services
5.2.1 Pre Sequencing Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 Sequencing Services
5.3.1 Sequencing Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Data Analysis Service
5.4.1 Data Analysis Service Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 6 END-USE BUSINESS ANALYSIS
6.1 Next Generation Sequencing Services Market: End-Use Movement Analysis
6.2 Universities & Other Research Entities
6.2.1 Next-Generation Sequencing Services Market For Universities & Other Research Entities, 2018 - 2030 (USD Million)
6.3 Hospitals & Clinics
6.3.1 Next-Generation Sequencing Services Market For Hospitals & Clinics, 2018 - 2030 (USD Million)
6.4 Pharma & Biotech Entities
6.4.1 Next-Generation Sequencing Services Market For Pharma & Biotech Entities, 2018 - 2030 (USD Million)
6.5 Others
6.5.1 Next-Generation Sequencing Services Market For Other End Use, 2018 - 2030 (USD Million)
CHAPTER 7 NEXT-GENERATION SEQUENCING SERVICES MARKET: REGIONAL ESTIMATES AND TREND ANALYSIS, BY SERVICE TYPE, WORKFLOW, & END-USE
7.1 North America
7.1.1 Swot Analysis:
7.1.1.1 North America Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.1.2 U.S.
7.1.2.1 Key Country Dynamics
7.1.2.2 Target Disease Prevalence
7.1.2.3 Competitive Scenario
7.1.2.4 Regulatory Framework
7.1.2.5 Reimbursement Scenario
7.1.2.6 U.S. Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.1.3 Canada
7.1.3.1 Key Country Dynamics
7.1.3.2 Target Disease Prevalence
7.1.3.3 Competitive Scenario
7.1.3.4 Regulatory Framework
7.1.3.5 Reimbursement Scenario
7.1.3.6 Canada Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.2 Europe
7.2.1 Swot Analysis:
7.2.1.1 Europe Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.2.2 Uk
7.2.2.1 Key Country Dynamics
7.2.2.2 Target Disease Prevalence
7.2.2.3 Competitive Scenario
7.2.2.4 Regulatory Framework
7.2.2.5 Reimbursement Scenario
7.2.2.6 Uk Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.2.3 Germany
7.2.3.1 Key Country Dynamics
7.2.3.2 Target Disease Prevalence
7.2.3.3 Competitive Scenario
7.2.3.4 Regulatory Framework
7.2.3.5 Reimbursement Scenario
7.2.3.6 Germany Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.2.4 France
7.2.4.1 Key Country Dynamics
7.2.4.2 Target Disease Prevalence
7.2.4.3 Competitive Scenario
7.2.4.4 Regulatory Framework
7.2.4.1 Reimbursement Scenario
7.2.4.2 France Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.2.5 Spain
7.2.5.1 Key Country Dynamics
7.2.5.2 Target Disease Prevalence
7.2.5.3 Competitive Scenario
7.2.5.4 Regulatory Framework
7.2.5.5 Reimbursement Scenario
7.2.5.6 Spain Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.2.6 Italy
7.2.6.1 Key Country Dynamics
7.2.6.2 Target Disease Prevalence
7.2.6.3 Competitive Scenario
7.2.6.4 Regulatory Framework
7.2.6.1 Reimbursement Scenario
7.2.6.2 Italy Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.2.7 Denmark
7.2.7.1 Key Country Dynamics
7.2.7.2 Target Disease Prevalence
7.2.7.3 Competitive Scenario
7.2.7.4 Regulatory Framework
7.2.7.5 Reimbursement Scenario
7.2.7.6 Denmark Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.2.8 Sweden
7.2.8.1 Key Country Dynamics
7.2.8.2 Target Disease Prevalence
7.2.8.3 Competitive Scenario
7.2.8.4 Regulatory Framework
7.2.8.1 Reimbursement Scenario
7.2.8.2 Sweden Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.2.9 Norway
7.2.9.1 Key Country Dynamics
7.2.9.2 Target Disease Prevalence
7.2.9.3 Competitive Scenario
7.2.9.4 Regulatory Framework
7.2.9.5 Reimbursement Scenario
7.2.9.6 Norway Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.2.10 Switzerland
7.2.10.1 Key Country Dynamics
7.2.10.2 Target Disease Prevalence
7.2.10.3 Competitive Scenario
7.2.10.4 Regulatory Framework
7.2.10.5 Reimbursement Scenario
7.2.10.6 Switzerland Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.3 Asia Pacific
7.3.1 Swot Analysis:
7.3.1.1 Asia Pacific Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.3.2 Japan
7.3.2.1 Key Country Dynamics
7.3.2.2 Target Disease Prevalence
7.3.2.3 Competitive Scenario
7.3.2.4 Regulatory Framework
7.3.2.5 Reimbursement Scenario
7.3.2.6 Japan Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.3.3 China
7.3.3.1 Key Country Dynamics
7.3.3.2 Target Disease Prevalence
7.3.3.3 Competitive Scenario
7.3.3.4 Regulatory Framework
7.3.3.5 Reimbursement Scenario
7.3.3.6 China Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.3.4 India
7.3.4.1 Key Country Dynamics
7.3.4.2 Target Disease Prevalence
7.3.4.3 Competitive Scenario
7.3.4.4 Regulatory Framework
7.3.4.5 Reimbursement Scenario
7.3.4.6 India Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.3.5 Australia
7.3.5.1 Key Country Dynamics
7.3.5.2 Target Disease Prevalence
7.3.5.3 Competitive Scenario
7.3.5.4 Regulatory Framework
7.3.5.5 Reimbursement Scenario
7.3.5.6 Australia Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.3.6 Thailand
7.3.6.1 Key Country Dynamics
7.3.6.2 Target Disease Prevalence
7.3.6.3 Competitive Scenario
7.3.6.4 Regulatory Framework
7.3.6.5 Reimbursement Scenario
7.3.6.6 Thailand Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.3.7 South Korea
7.3.7.1 Key Country Dynamics
7.3.7.2 Target Disease Prevalence
7.3.7.3 Competitive Scenario
7.3.7.4 Regulatory Framework
7.3.7.5 Reimbursement Scenario
7.3.7.6 South Korea Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.3.8 Singapore
7.3.8.1 Key Country Dynamics
7.3.8.2 Target Disease Prevalence
7.3.8.3 Competitive Scenario
7.3.8.4 Regulatory Framework
7.3.8.5 Reimbursement Scenario
7.3.8.6 Singapore Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.4 Latin America
7.4.1 Swot Analysis:
7.4.1.1 Latin America Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.4.2 Brazil
7.4.2.1 Key Country Dynamics
7.4.2.2 Target Disease Prevalence
7.4.2.3 Competitive Scenario
7.4.2.4 Regulatory Framework
7.4.2.5 Reimbursement Scenario
7.4.2.6 Brazil Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.4.3 Mexico
7.4.3.1 Key Country Dynamics
7.4.3.2 Target Disease Prevalence
7.4.3.3 Competitive Scenario
7.4.3.4 Regulatory Framework
7.4.3.5 Reimbursement Scenario
7.4.3.6 Mexico Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.4.4 Argentina
7.4.4.1 Key Country Dynamics
7.4.4.2 Target Disease Prevalence
7.4.4.3 Competitive Scenario
7.4.4.4 Regulatory Framework
7.4.4.5 Reimbursement Scenario
7.4.4.6 Argentina Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.5 Mea
7.5.1 Swot Analysis:
7.5.1.1 Mea Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.5.2 South Africa
7.5.2.1 Key Country Dynamics
7.5.2.2 Target Disease Prevalence
7.5.2.3 Competitive Scenario
7.5.2.4 Regulatory Framework
7.5.2.5 Reimbursement Scenario
7.5.2.6 South Africa Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.5.3 Saudi Arabia
7.5.3.1 Key Country Dynamics
7.5.3.2 Target Disease Prevalence
7.5.3.3 Competitive Scenario
7.5.3.4 Regulatory Framework
7.5.3.5 Reimbursement Scenario
7.5.3.6 Saudi Arabia Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.5.4 Uae
7.5.4.1 Key Country Dynamics
7.5.4.2 Target Disease Prevalence
7.5.4.3 Competitive Scenario
7.5.4.4 Regulatory Framework
7.5.4.5 Reimbursement Scenario
7.5.4.6 Uae Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
7.5.5 Kuwait
7.5.5.1 Key Country Dynamics
7.5.5.2 Target Disease Prevalence
7.5.5.3 Competitive Scenario
7.5.5.4 Regulatory Framework
7.5.5.5 Reimbursement Scenario
7.5.5.6 Kuwait Ngs Services Market Estimates And Forecasts, 2018–2030, (Usd Million)
CHAPTER 8 COMPETITIVE LANDSCAPE
8.1 Company Categorization
8.2 Company Market Share Analysis, 2022
8.3 Strategy Mapping
8.4 Company Profiles/Listing
8.4.1 QUEST DIAGNOSTICS INCORPORATED
8.4.1.1 Overview
8.4.1.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3 Product Benchmarking
8.4.1.4 Strategic Initiatives
8.4.2 ARUP LABORATORIES
8.4.2.1 Overview
8.4.2.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3 Product Benchmarking
8.4.2.4 Strategic Initiatives
8.4.3 APPLIED BIOLOGICAL MATERIALS, INC. (ABM)
8.4.3.1 Overview
8.4.3.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3 Product Benchmarking
8.4.3.4 Strategic Initiatives
8.4.4 NOVOGENE CO, LTD.
8.4.4.1 Overview
8.4.4.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3 Product Benchmarking
8.4.4.4 Strategic Initiatives
8.4.5 AZENTA LIFE SCIENCES (GENEWIZ)
8.4.5.1 Overview
8.4.5.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3 Product Benchmarking
8.4.5.4 Strategic Initiatives
8.4.6 NANOSTRING
8.4.6.1 Overview
8.4.6.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3 Product Benchmarking
8.4.6.4 Strategic Initiatives
8.4.7 ILLUMINA, INC.
8.4.7.1 Overview
8.4.7.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3 Product Benchmarking
8.4.7.4 Strategic Initiatives
8.4.8 PACBIO
8.4.8.1 Overview
8.4.8.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3 Product Benchmarking
8.4.8.4 Strategic Initiatives
8.4.9 VERITAS
8.4.9.1 Overview
8.4.9.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3 Product Benchmarking
8.4.9.4 Strategic Initiatives
8.4.10 BGI (BEIJING GENOMICS INSTITUTE)
8.4.10.1 Overview
8.4.10.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3 Product Benchmarking
8.4.10.4 Strategic Initiatives
8.4.11 GENE BY GENE LTD.
8.4.11.1 Overview
8.4.11.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.11.3 Product Benchmarking
8.4.11.4 Strategic Initiatives
8.4.12 LUCIGEN CORPORATION
8.4.12.1 Overview
8.4.12.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.12.3 Product Benchmarking
8.4.12.4 Strategic Initiatives
LIST OF TABLES
Table 1 Illumina workflows to address COVID-19
Table 2 Illumina workflows to address COVID-19
Table 3 Next-generation sequencing service providers in the U.S.:
Table 4 Regulatory policies in Singapore
Table 5 Key companies undertaking expansion
Table 6 Key companies undertaking acquisitions
Table 7 Key companies undergoing collaborations
Table 8 Key companies launching new products/services
Table 9 Key companies undergoing partnerships
Table 10 Key companies undergoing other strategies
Table 11 North America next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 12 North America next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 13 North America next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 14 North America next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 15 U.S. next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 16 U.S. next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 17 U.S. next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 18 U.S. next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 19 Canada next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 20 Canada next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 21 Canada next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 22 Canada next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 23 Europe next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 24 Europe next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 25 Europe next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 26 Europe next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 27 Germany next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 28 Germany next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 29 Germany next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 30 Germany next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 31 UK next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 32 UK next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 33 UK next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 34 UK next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 35 France next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 36 France next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 37 France next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 38 France next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 39 Italy next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 40 Italy next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 41 Italy next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 42 Italy next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 43 Spain next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 44 Spain next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 45 Spain next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 46 Spain next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 47 Denmark next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 48 Denmark next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 49 Denmark next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 50 Denmark next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 51 Sweden next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 52 Sweden next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 53 Sweden next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 54 Sweden next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 55 Norway next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 56 Norway next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 57 Norway next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 58 Norway next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 59 Switzerland next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 60 Switzerland next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 61 Switzerland next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 62 Switzerland next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 63 Asia Pacific next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 64 Asia Pacific next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 65 Asia Pacific next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 66 Asia Pacific next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 67 Japan next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 68 Japan next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 69 Japan next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 70 Japan next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 71 China next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 72 China next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 73 China next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 74 China next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 75 India next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 76 India next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 77 India next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 78 India next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 79 Australia next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 80 Australia next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 81 Australia next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 82 Australia next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 83 South Korea next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 84 South Korea next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 85 South Korea next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 86 South Korea next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 87 Thailand next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 88 Thailand next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 89 Thailand next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 90 Thailand next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 91 Singapore next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 92 Singapore next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 93 Singapore next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 94 Singapore next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 95 Latin America next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 96 Latin America next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 97 Latin America next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 98 Latin America next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 99 Brazil next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 100 Brazil next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 101 Brazil next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 102 Brazil next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 103 Mexico next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 104 Mexico next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 105 Mexico next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 106 Mexico next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 107 Argentina next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 108 Argentina next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 109 Argentina next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 110 Argentina next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 111 MEA next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 112 MEA next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 113 MEA next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 114 MEA next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 115 South Africa next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 116 South Africa next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 117 South Africa next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 118 South Africa next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 119 Saudi Arabia next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 120 Saudi Arabia next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 121 Saudi Arabia next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 122 Saudi Arabia next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 123 UAE next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 124 UAE next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 125 UAE next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 126 UAE next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 127 Kuwait next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 128 Kuwait next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 129 Kuwait next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 130 Kuwait next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 1 Illumina workflows to address COVID-19
Table 2 Illumina workflows to address COVID-19
Table 3 Next-generation sequencing service providers in the U.S.:
Table 4 Regulatory policies in Singapore
Table 5 Key companies undertaking expansion
Table 6 Key companies undertaking acquisitions
Table 7 Key companies undergoing collaborations
Table 8 Key companies launching new products/services
Table 9 Key companies undergoing partnerships
Table 10 Key companies undergoing other strategies
Table 11 North America next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 12 North America next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 13 North America next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 14 North America next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 15 U.S. next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 16 U.S. next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 17 U.S. next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 18 U.S. next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 19 Canada next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 20 Canada next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 21 Canada next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 22 Canada next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 23 Europe next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 24 Europe next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 25 Europe next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 26 Europe next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 27 Germany next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 28 Germany next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 29 Germany next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 30 Germany next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 31 UK next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 32 UK next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 33 UK next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 34 UK next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 35 France next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 36 France next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 37 France next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 38 France next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 39 Italy next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 40 Italy next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 41 Italy next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 42 Italy next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 43 Spain next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 44 Spain next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 45 Spain next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 46 Spain next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 47 Denmark next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 48 Denmark next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 49 Denmark next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 50 Denmark next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 51 Sweden next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 52 Sweden next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 53 Sweden next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 54 Sweden next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 55 Norway next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 56 Norway next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 57 Norway next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 58 Norway next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 59 Switzerland next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 60 Switzerland next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 61 Switzerland next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 62 Switzerland next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 63 Asia Pacific next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 64 Asia Pacific next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 65 Asia Pacific next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 66 Asia Pacific next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 67 Japan next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 68 Japan next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 69 Japan next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 70 Japan next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 71 China next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 72 China next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 73 China next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 74 China next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 75 India next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 76 India next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 77 India next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 78 India next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 79 Australia next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 80 Australia next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 81 Australia next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 82 Australia next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 83 South Korea next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 84 South Korea next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 85 South Korea next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 86 South Korea next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 87 Thailand next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 88 Thailand next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 89 Thailand next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 90 Thailand next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 91 Singapore next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 92 Singapore next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 93 Singapore next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 94 Singapore next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 95 Latin America next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 96 Latin America next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 97 Latin America next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 98 Latin America next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 99 Brazil next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 100 Brazil next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 101 Brazil next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 102 Brazil next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 103 Mexico next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 104 Mexico next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 105 Mexico next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 106 Mexico next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 107 Argentina next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 108 Argentina next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 109 Argentina next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 110 Argentina next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 111 MEA next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 112 MEA next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 113 MEA next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 114 MEA next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 115 South Africa next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 116 South Africa next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 117 South Africa next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 118 South Africa next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 119 Saudi Arabia next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 120 Saudi Arabia next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 121 Saudi Arabia next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 122 Saudi Arabia next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 123 UAE next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 124 UAE next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 125 UAE next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 126 UAE next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 127 Kuwait next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 128 Kuwait next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
Table 129 Kuwait next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 130 Kuwait next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Segment snapshot
Fig. 10 Segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Market trends & outlook
Fig. 13 Market driver impact
Fig. 14 DNA sequencing: Cost per MB of, 2010 to August 2020
Fig. 15 Cost of per human genome, 2010 to August 2020
Fig. 16 Estimated new in situ and invasive breast cancer cases among women by age, US, 2022
Fig. 17 Current advancements in NGS technology for breast cancer
Fig. 18 Market restraint impact
Fig. 19 Overview of challenges in the design and execution of NGS analysis workflow
Fig. 20 Penetration and growth prospect mapping
Fig. 21 Key macroeconomic challenges associated with the pandemic
Fig. 22 Key elements to enhance the supply chain post COVID
Fig. 23 Role of NGS to combat COVID-19 outbreak
Fig. 24 Workflow Comparison
Fig. 25 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 26 Porter’s Five Forces Analysis
Fig. 27 Next-generation sequencing services market: Service type outlook and key takeaways
Fig. 28 Next-generation sequencing services market: Service type movement analysis
Fig. 29 Human genome sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Single-cell sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Microbial genome-based sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Gene regulation services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Small RNA sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Chip sequencing service market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Other gene regulation-based service market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Animal & plant sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Other sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Next-generation sequencing services market: Workflow outlook and key takeaways
Fig. 39 Next generation sequencing services market: Workflow movement analysis
Fig. 40 Pre sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Data analysis service market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Next-generation sequencing services market: End-use outlook and key takeaways
Fig. 44 Next-generation sequencing services market: End-use movement analysis
Fig. 45 Next-generation sequencing services market for universities & other research entities, 2018 - 2030 (USD Million)
Fig. 46 Next-generation sequencing services market for hospitals & clinics, 2018 - 2030 (USD Million)
Fig. 47 Next-generation sequencing services market for pharma & biotech entities, 2018 - 2030 (USD Million)
Fig. 48 Next-generation sequencing services market for other end use, 2018 - 2030 (USD Million)
Fig. 49 Regional marketplace: Key takeaways
Fig. 50 Regional marketplace: Key takeaways
Fig. 51 North America: SWOT analysis
Fig. 52 North America NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Key country dynamics
Fig. 54 Target disease prevalence (patient volume) ('000), 2018 - 2030
Fig. 55 Ways to obtain coverage
Fig. 56 U.S. NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 Major therapeutic classes share, (%)
Fig. 59 Canada NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Europe: SWOT analysis
Fig. 61 Europe NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 Cancer prevalence, 2021
Fig. 64 UK NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Number of new cancer cases in 2020, both sexes, all ages
Fig. 67 Germany NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 France CNS/Neurology scenario
Fig. 70 France NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 Number of new cancer cases in 2020, both sexes, all ages
Fig. 73 Spain NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Cancer prevalence (%)
Fig. 76 Italy NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 Target disease prevalence
Fig. 79 Denmark NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 Disease prevalence
Fig. 82 Sweden NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Key country dynamics
Fig. 84 Disease prevalence
Fig. 85 Norway NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Key country dynamics
Fig. 87 People with diabetes, in 1,000s
Fig. 88 Switzerland NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Asia Pacific SWOT analysis
Fig. 90 Asia Pacific NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 Key country dynamics
Fig. 92 Cancer prevalence in Japan
Fig. 93 Japan NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 Key country dynamics
Fig. 95 Prevalence of major diseases in China
Fig. 96 China NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 97 Key country dynamics
Fig. 98 Diabetes prevalence in India
Fig. 99 India NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 100 Key country dynamics
Fig. 101 Chronic diseases prevalence in Australia, 2020-2021
Fig. 102 Australia NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 103 Key country dynamics
Fig. 104 Number of new cancer cases in 2020, both sexes, all ages
Fig. 105 Regulations details of Thailand
Fig. 106 Thailand NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 107 Key country dynamics
Fig. 108 Number of new cancer cases in 2020, both sexes, all ages
Fig. 109 South Korea NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 110 Key country dynamics
Fig. 111 Number of new cancer cases in 2020, both sexes, all ages
Fig. 112 Singapore NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 113 Latin America: SWOT analysis
Fig. 114 Latin America NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 115 Key country dynamics
Fig. 116 Cancer incidence. 2020-2030
Fig. 117 Brazil NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 118 Key country dynamics
Fig. 119 Prostate cancer burden, 2018 - 2030
Fig. 120 Mexico NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 121 Key country dynamics
Fig. 122 Number of new cancer cases in 2020, both sexes, all ages
Fig. 123 Argentina NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 124 MEA: SWOT analysis
Fig. 125 MEA NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 126 Key country dynamics
Fig. 127 Disease incidence change (%), 2009-2019
Fig. 128 South Africa NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 129 Key country dynamics
Fig. 130 Causes of death in Saudi Arabia
Fig. 131 Saudi Arabia NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 132 Key country dynamics
Fig. 133 Target disease prevalence
Fig. 134 UAE NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 135 Key country dynamics
Fig. 136 Target disease prevalence
Fig. 137 Kuwait NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 138 Market participant categorization
Fig. 139 NGS services market share analysis, 2022
Fig. 140 Strategic framework
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Segment snapshot
Fig. 10 Segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Market trends & outlook
Fig. 13 Market driver impact
Fig. 14 DNA sequencing: Cost per MB of, 2010 to August 2020
Fig. 15 Cost of per human genome, 2010 to August 2020
Fig. 16 Estimated new in situ and invasive breast cancer cases among women by age, US, 2022
Fig. 17 Current advancements in NGS technology for breast cancer
Fig. 18 Market restraint impact
Fig. 19 Overview of challenges in the design and execution of NGS analysis workflow
Fig. 20 Penetration and growth prospect mapping
Fig. 21 Key macroeconomic challenges associated with the pandemic
Fig. 22 Key elements to enhance the supply chain post COVID
Fig. 23 Role of NGS to combat COVID-19 outbreak
Fig. 24 Workflow Comparison
Fig. 25 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 26 Porter’s Five Forces Analysis
Fig. 27 Next-generation sequencing services market: Service type outlook and key takeaways
Fig. 28 Next-generation sequencing services market: Service type movement analysis
Fig. 29 Human genome sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Single-cell sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Microbial genome-based sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Gene regulation services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Small RNA sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Chip sequencing service market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Other gene regulation-based service market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Animal & plant sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Other sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Next-generation sequencing services market: Workflow outlook and key takeaways
Fig. 39 Next generation sequencing services market: Workflow movement analysis
Fig. 40 Pre sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Data analysis service market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Next-generation sequencing services market: End-use outlook and key takeaways
Fig. 44 Next-generation sequencing services market: End-use movement analysis
Fig. 45 Next-generation sequencing services market for universities & other research entities, 2018 - 2030 (USD Million)
Fig. 46 Next-generation sequencing services market for hospitals & clinics, 2018 - 2030 (USD Million)
Fig. 47 Next-generation sequencing services market for pharma & biotech entities, 2018 - 2030 (USD Million)
Fig. 48 Next-generation sequencing services market for other end use, 2018 - 2030 (USD Million)
Fig. 49 Regional marketplace: Key takeaways
Fig. 50 Regional marketplace: Key takeaways
Fig. 51 North America: SWOT analysis
Fig. 52 North America NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Key country dynamics
Fig. 54 Target disease prevalence (patient volume) ('000), 2018 - 2030
Fig. 55 Ways to obtain coverage
Fig. 56 U.S. NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 Major therapeutic classes share, (%)
Fig. 59 Canada NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Europe: SWOT analysis
Fig. 61 Europe NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 Cancer prevalence, 2021
Fig. 64 UK NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Number of new cancer cases in 2020, both sexes, all ages
Fig. 67 Germany NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 France CNS/Neurology scenario
Fig. 70 France NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 Number of new cancer cases in 2020, both sexes, all ages
Fig. 73 Spain NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Cancer prevalence (%)
Fig. 76 Italy NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 Target disease prevalence
Fig. 79 Denmark NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 Disease prevalence
Fig. 82 Sweden NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Key country dynamics
Fig. 84 Disease prevalence
Fig. 85 Norway NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Key country dynamics
Fig. 87 People with diabetes, in 1,000s
Fig. 88 Switzerland NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Asia Pacific SWOT analysis
Fig. 90 Asia Pacific NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 Key country dynamics
Fig. 92 Cancer prevalence in Japan
Fig. 93 Japan NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 Key country dynamics
Fig. 95 Prevalence of major diseases in China
Fig. 96 China NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 97 Key country dynamics
Fig. 98 Diabetes prevalence in India
Fig. 99 India NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 100 Key country dynamics
Fig. 101 Chronic diseases prevalence in Australia, 2020-2021
Fig. 102 Australia NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 103 Key country dynamics
Fig. 104 Number of new cancer cases in 2020, both sexes, all ages
Fig. 105 Regulations details of Thailand
Fig. 106 Thailand NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 107 Key country dynamics
Fig. 108 Number of new cancer cases in 2020, both sexes, all ages
Fig. 109 South Korea NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 110 Key country dynamics
Fig. 111 Number of new cancer cases in 2020, both sexes, all ages
Fig. 112 Singapore NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 113 Latin America: SWOT analysis
Fig. 114 Latin America NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 115 Key country dynamics
Fig. 116 Cancer incidence. 2020-2030
Fig. 117 Brazil NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 118 Key country dynamics
Fig. 119 Prostate cancer burden, 2018 - 2030
Fig. 120 Mexico NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 121 Key country dynamics
Fig. 122 Number of new cancer cases in 2020, both sexes, all ages
Fig. 123 Argentina NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 124 MEA: SWOT analysis
Fig. 125 MEA NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 126 Key country dynamics
Fig. 127 Disease incidence change (%), 2009-2019
Fig. 128 South Africa NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 129 Key country dynamics
Fig. 130 Causes of death in Saudi Arabia
Fig. 131 Saudi Arabia NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 132 Key country dynamics
Fig. 133 Target disease prevalence
Fig. 134 UAE NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 135 Key country dynamics
Fig. 136 Target disease prevalence
Fig. 137 Kuwait NGS services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 138 Market participant categorization
Fig. 139 NGS services market share analysis, 2022
Fig. 140 Strategic framework
